CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic diseases, enhancing crops, and engineering ...

For the last few years, the narrative around Generative AI in science has largely focused on administrative efficiency – ...

Earlier in January 2026, Illumina announced the Billion Cell Atlas alliance with AstraZeneca, Merck, and Eli Lilly, alongside new AI‑enabled genomics and multiomics platforms that integrate CRISPR, ...

Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial intelligence, will help accelerate drug discovery. Dubbed the Billion Cell ...

At our university, professor Brian Sayre was appointed to lead our campus artificial intelligence (AI) educational and ...

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and validate drug targets and train AI models used in drug discovery.

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...

Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through ‍artificial intelligence. The company said it was partnering with ...

ChatGPT predicted AI engineers, cybersecurity directors, cloud architects and biotech specialists will earn $200,000+ by 2030 ...

Pella Corporation, a leading manufacturer of windows and doors, celebrated the opening of the Pella Corporation Wellness ...

Senate Bill 895 would place a $23 billion bond before voters in November 2026 to fund scientific research across California, ...